PanGen Biotech Inc Total Liabilities

Latest as of September 2025: ₩2.74 Billion KRW ≈ $1.86 Million USD

PanGen Biotech Inc total liabilities. Based on the latest financial reports, PanGen Biotech Inc (222110) has total liabilities worth ₩2.74 Billion KRW (≈ $1.86 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of PanGen Biotech Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of PanGen Biotech Inc (2014–2024)

Total liabilities of PanGen Biotech Inc from 2014 to 2024. This chart illustrates how PanGen Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of PanGen Biotech Inc to see how much of total assets are deployed in long-term investments.

PanGen Biotech Inc Competitors by Total Liabilities

The table below lists competitors of PanGen Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Stablecoin Development Corporation NYSE MKT:SDEV	USA	$33.47 Million
SMCore.Inc KQ:007820	Korea	₩54.09 Billion
Buima Group TWO:5543	Taiwan	NT$1.90 Billion
Sambo Motors Co. Ltd KQ:053700	Korea	₩992.06 Billion
Helbor Empreendimentos S.A SA:HBOR3	Brazil	R$3.91 Billion
Grande Portage Resources Ltd V:GPG	Canada	CA$398.30K
Saeron Auto KO:075180	Korea	₩32.59 Billion
Delticom AG F:DEX	Germany	€161.18 Million

Liability Composition Analysis (2014–2024)

This chart breaks down PanGen Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PanGen Biotech Inc asset portfolio.

Liquidity & Leverage Metrics

PanGen Biotech Inc Total Liabilities Ratios Explained

PanGen Biotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	8.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.08	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how PanGen Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for PanGen Biotech Inc (2014–2024)

The table below shows the annual total liabilities of PanGen Biotech Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩5.64 Billion ≈ $3.82 Million	-31.06%
2023-12-31	₩8.18 Billion ≈ $5.54 Million	+136.67%
2022-12-31	₩3.45 Billion ≈ $2.34 Million	-84.43%
2021-12-31	₩22.18 Billion ≈ $15.03 Million	+0.37%
2020-12-31	₩22.10 Billion ≈ $14.98 Million	+6.98%
2019-12-31	₩20.66 Billion ≈ $14.00 Million	+10.65%
2018-12-31	₩18.67 Billion ≈ $12.65 Million	+335.84%
2017-12-31	₩4.28 Billion ≈ $2.90 Million	+104.76%
2016-12-31	₩2.09 Billion ≈ $1.42 Million	-77.60%
2015-12-31	₩9.34 Billion ≈ $6.33 Million	+50.99%
2014-12-31	₩6.18 Billion ≈ $4.19 Million	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$37.49 Million

₩55.33 Billion KRW

Market Cap Rank

#22756 Global

#1497 in Korea

Share Price

₩4100.00

Change (1 day)

-0.24%

52-Week Range

₩4100.00 - ₩7340.00

All Time High

₩24450.00